Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

RATIONALE: There is no consensus as to when treatment for idiopathic pulmonary fibrosis (IPF) should be initiated. Some physicians prefer not to treat patients with preserved lung volume. OBJECTIVE: To investigate whether patients with IPF and preserved lung volume receive the same benefit from nint...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorax
Main Authors: Kolb, Martin, Richeldi, Luca, Behr, Jürgen, Maher, Toby M, Tang, Wenbo, Stowasser, Susanne, Hallmann, Christoph, du Bois, Roland M
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2017
Fag:
Interstitial Lung Disease
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520269/
https://ncbi.nlm.nih.gov/pubmed/27672117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2016-208710
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker